[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100548579":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":18,"responsibleParty":35,"collaborators":18,"id":38,"slug":18,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":43,"eligibilityCriteria":44,"healthyVolunteers":39,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":18,"studyType":51,"phases":52,"briefSummary":54,"conditions":55,"keywords":58,"overallStatus":62,"whyStopped":18,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":18},{"fullName":5,"class":6},"Unidade Local de Saúde de Coimbra, EPE","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Interventional group","EXPERIMENTAL","In this group the respective algorithm will be activated and alerts will be sent according to its design",[13],"Other: HeartLogic or TriageHF Algorithms for implantable devices",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group","NO_INTERVENTION","The algorithm will not be activated and follow-up will continue as if the patient was not included in the study.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"HeartLogic or TriageHF Algorithms for implantable devices","Activation of the HeartLogic and TriageHF algorithms for implantable devices and correctly act according to its design",[9],[25],{"name":26,"affiliation":27,"role":28},"Gonçalo Batista, MD","ULS Coimbra","PRINCIPAL_INVESTIGATOR",[30],{"name":26,"role":31,"phone":32,"phoneExt":33,"email":34},"CONTACT","963596295","00351","goncalo96batista@gmail.com",{"type":28,"investigatorFullName":36,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Goncalo Terleira Batista","Cardiology Resident","100548579",false,"NCT06422832","Remote Monitoring To Identify Worsening Heart Failure The REMOTI-HF Randomized Clinical Trial","Remote Monitoring To Identify Worsening Heart Failure: The REMOTI-HF Randomized Clinical Trial","REMOTI-HF","Inclusion Criteria:\n\n* Possession of an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) device that is compatible with the HeartLogic or TriageHF algorithms.\n* Left ventricular ejection fraction at the time of device implantation must be equal to or less than 35%.\n\nExclusion Criteria:\n\n* Younger than 18 years old or older than 85 years old.\n* Unable to be contacted when out of the hospital.\n* Presence of severe cognitive impairment.\n* Currently on the heart transplant waiting list","ALL","18 Years","85 Years",{"count":49,"type":50},270,"ESTIMATED","INTERVENTIONAL",[53],"NA","Heart failure, characterized by high mortality and morbidity rates, frequent hospital admissions, and prolonged stays in cardiology wards, significantly impacts patients' quality of life.\n\nThe REMOTI-HF is a single-center randomized controlled trial designed to assess the impact of remote monitoring, utilizing the HeartLogic and TriageHF algorithms, in patients with heart failure with implantable cardioverter defibrillator or cardiac resynchronization therapy. The primary endpoints include mortality, hospital admissions related to heart failure, and visits for worsening heart failure.\n\nMoreover, we will explore the full capabilities of these algorithms, by analysing the association of physical activity, measured by the devices, with the same key outcomes. Additionally, the research will explore the relationship between the absolute values provided by the algorithms and NT-proBNP values.",[56,57],"Heart Failure","Arrythmia",[56,59,60,61],"Remote Monitoring","ICD","CRT","NOT_YET_RECRUITING","2024-05-15",{"date":65,"type":66},"2024-05-21","ACTUAL",{"date":68,"type":50},"2024-07-01",{"date":70,"type":50},"2026-07-01",{"name":5,"class":6}]